Anavex Life Sciences Corp (AVXL)

[frrol]

The Cassava interim results are nice to see. There's potential signal there and worth pursuing, which they'll clearly do. Since it's a small n and open label, it's a '2 out of 10' on the proof meter. They have a ways to go.

Nothing about it makes me want to invest in it (vs AVXL). I still find our risk/reward much more attractive.

Folks should note how the Cassava trial design and circumstances differ from our trial in a couple important ways to justify their interim peak. (This is not to say we wouldn't do an interim, but that we have fewer reasons to. Hence Missling's reticence.)